Abilify Compulsive Behavior | Abilify Lawsuit • Carlson Law Firm
Legal Representation for Victims of Abilify Compulsive Disorder
Free Consultation • Available 24/7
Thousands of people have filed lawsuits against Abilify maker Otsuka Pharmaceutical Co. and Bristol-Myers Squibb the company responsible for marketing the drug in the United States and other countries. These lawsuits come as research continues to link the drug to increased risks of users developing pathological compulsive behaviors. In fact, these behaviors are dramatic and can have extremely negative impacts on a person’s life. Abilify compulsive behavior includes everything from excessive gambling to binge eating. If you or a loved one had your life upended because of unintended effects while using Abilify, contact The Carlson Law Firm to schedule a free consultation with an Abilify Lawsuit Attorney.
The Carlson Law Firm has more than 40 years representing victims of dangerous drugs. If you took Abilify and experienced gambling losses or developed compulsive sexual habits, contact an Abilify Lawsuit Attorney from our firm. We can help you determine if filing a lawsuit against the makers and marketers of Abilify is the right step for you.
What is Abilify?
Abilify, or aripiprazole, is an antipsychotic that alters brain chemical activity. Further, Abilify comes as an oral tablet, orally disintegrating tablets or oral solution. It is part of a group of drugs called atypical antipsychotics or second-generation antipsychotics. Abilify is prescribed as a treatment for several mental disorders.
Second-generation antipsychotic drugs carry a lower risk of movement disorders such as Parkinsonism. However, they have a higher risk of metabolic side effects, such as:
- Weight gain
- Increased blood sugar
- Blood pressure; and
If a doctor prescribed you Abilify and you developed Abilify compulsive disorders, you may be able to seek compensation from the manufacturers. Contact The Carlson Law Firm to schedule a consultation with a qualified Abilify lawsuit attorney.
What does Abilify Treat?
The Food and Drug Administration approved Abilify to treat schizophrenia. Schizophrenia is a serious mental illness that causes disordered thoughts, emotion, and behavior. In addition to schizophrenia, the drug treats:
- Manic or mixed episodes that happen in bipolar disorder
- Major depressive disorder when used with antidepressant medicines
- Irritability associated with autism
- Tourette’s disorder
Additionally, medical professional may use Abilify injections to treat agitation associated with schizophrenia or bipolar mania.
If you received Abilify for any of the above conditions and developed a gambling addiction or hypersexuality, contact The Carlson Law Firm. We have an Abilify Lawsuit Attorney ready to help you navigate your legal claim.
How does Abilify Treat Mental Illness?
Abilify works by altering the activity of natural substances in the brain. In particular, the drug stabilizes dopamine and serotonin—two neurotransmitters responsible for a significant portion of psychiatric symptoms and behaviors.
Dosage amounts depend on a patient’s condition. However, the drug comes standard in tablet form in the following dosage amounts:
If you took any dosage amount and developed a harmful Abilify Compulsive Behavior contact an Abilify Lawsuit Attorney from The Carlson Law Firm. We can help get you started on your road to recovery.
Abilify Side Effects
Suicidal thoughts are likely to occur in children, teens and young adults who take Abilify. As a result, doctors should use caution when prescribing this drug to minors and young adults.
Common side effects of the drug include the following:
- Upset stomach
- Excess saliva or drooling
- Choking or trouble swallowing.
In addition to the symptoms, more severe side effects may occur:
In addition to these side effects, the drug can lead to a rare condition called neuroleptic malignant syndrome. The condition is life-threatening and is the result of antipsychotic drugs. Characterized by fever, altered mental status, muscle rigidity and autonomic dysfunction, it is an adverse reaction to medications with dopamine receptor-antagonist properties or the rapid withdrawal of dopaminergic medications.
While these conditions are serious, they were all noted on Abilify’s warning label. Because of this, injuries sustained from these side effects are not being pursued in lawsuits at this time. However, if you or a loved one suffered harm from Abilify through a compulsive behavior, contact a Carlson Law Firm
What Causes Abilify Compulsive Behavior?
In short, Abilify influences an individual’s feelings of pleasure; which can lead to addictive behavior. Patients on the drug can’t stop performing actions causing them or their loved ones harm—even though they desperately want to stop. Abilify affects a patient’s dopamine level. Dopamine is a neurotransmitter responsible for sending positive feeling signals between the nerve cells of the brain.
Equally important, the issue affecting patients who have used Abilify is not just limited to the United States. In reality, patients all over the world report that Abilify turned them into compulsive gamblers, eaters or sex addicts. Abilify injuries include the following:
- Compulsive or pathological gambling
- Compulsive spending
- Compulsive or binge eating
- Urges to steal or shoplift
- Involuntary movement
- Suicidal thoughts
If you or a loved one suffered Abilify compulsive behaviors, contact The Carlson Law Firm. We have an Abilify Lawsuit Attorney who can help you navigate the complex legal system to get the compensation you deserve.
International Knowledge and Abilify Warning Label Updates
Otsuka issued a Periodic Safety Update Report on Abilify to the European Medicines Agency (EMA) in 2011. The report detailed 23 serious reports of pathological gambling among patients taking Abilify. In 2012, the EMA reported that post-marketing reports have been found among patients prescribed Abilify, regardless of prior gambling history. Further, the report noted that individuals who do have a prior history of excessive gambling may be at increased risk and should be monitored when using Abilify.
As a result of its finding, Europe required Otsuka to issue a warning on the drug’s label concerning the link between Abilify and compulsive gambling.
Similarly, Health Canada issued a safety review on Abilify. The organization reviewed 18 instances of patients around the globe engaging in compulsive gambling and six cases of hypersexuality. According to the report, 14 out of the 18 gambling cases were resolved when the patient stopped taking Abilify. Also, five of the six hypersexuality cases stopped when the patients stopped taking the drug.
Abilify U.S. Warning Label Changes
In May 2016, the FDA issued a boxed warning about Abilify compulsive behavior. The FDA explained that the warning label was added in response to approximately 200 reported cases of compulsive gambling, eating, shopping or hypersexuality by patients taking Abilify. It was only after the FDA warning that the makers of Abilify decided to make American patients and doctors aware of the risks, despite knowing about the adverse affects from as early as 2012.
Abilify Black Box Warning Label
The black box warning label is the most serious drug label warning that the FDA requires. And Abilify carries two.
The first warns patients that the FDA has not approved Abilify to treat dementia-related psychosis. Elderly patients who are treated for dementia with Abilify have a higher risk of death. To summarize, elderly patients given Abilify are at an increased risk of stroke.
The second black box warning highlights the dangers of using the drug in children, adolescents and young adults with a major depressive disorder or other psychiatric disorders. Young patients experience a higher risk of suicidal thinking when taking Abilify.
How are Otsuka Pharmaceutical and Bristol-Myers Squibb guilty?
Despite growing concerns over stroke risks in the elderly and causing compulsive behaviors in adults, Bristol-Myers Squibb continues to market Abilify as a safe and effective treatment for psychological disorders. As a result, the companies are guilty of failing to warn patients and doctors that Abilify can cause these and other compulsive disorders.
The aggressive marketing continued for years without an update to the drug’s U.S. label, despite European and Canadian health officials increasing regulation of Abilify. The increase in regulation required changes to the drug’s label and marketing materials. For example, the changes ensured that doctors and patients were informed of the possible risks of using antipsychotic drugs.
In 2016, the United States Judicial Panel on Multidistrict Litigation ruled that all federal lawsuits involving Abilify compulsive behaviors would be handled by a federal judge in the Northern District of Florida.
In May 2018, the first three cases scheduled for trial settled for undisclosed amounts. All three plaintiffs claimed that the drug made them gamble compulsively. However, the cases settled just weeks before trials were to begin.
Abilify in Other Courts
In May 2018, the New Jersey Supreme Court agreed to consolidate 42 Abilify lawsuits into multicounty litigation.
In Aug. 2018, 17 plaintiffs filed lawsuits in the Philadelphia Court of Common Pleas.
In both of these instances, the lawsuits claim that Abilify caused compulsive behaviors such as gambling, shopping, hypersexuality and binge eating.
Previous Abilify Settlements
2005: Bristol-Myers Squibb paid a $515 million penalty to the U.S. government to settle claims that the company marketing the drug for “off-label” purpose.
2008: Otsuka Pharmaceutical paid the U.S. government $4 million to settle claims that the company marketing the drug to child psychiatrists and nursing homes for unapproved off-label use. Many doctors prescribed the drug to elderly patients with dementia-induced psychosis. Further, doctors prescribed it to children with autism to help with aggression and mood swings. While it isn’t illegal for doctors to prescribe medication for off-label use, it is illegal for manufacturers to market the drug for off-label uses. None of the off-label uses for Abilify have been studied for efficacy or safety. In fact, the drug is not approved for any of these uses.
December 2016: the U.S. Justice Department settled with Bristol-Myers Squibb worth $19.5 million. The lawsuit stemmed from the company’s unlawful marketing and downplaying of the drug’s risks.
Other Abilify Lawsuits
In July 2018, a federal judge in West Virginia ruled against a man who sued Bristol-Myers Squibb for leading to his development of tardive dyskinesia. The judge further noted that Abilify label carried a detailed warning about tardive dyskinesia.
Tardive dyskinesia is a condition of the nervous system where a suffer is afflicted with involuntary movements. The movement typically involves facial ticks, jaw clenching and clucking and eye blinking.
Can I file an Abilify Lawsuit?
Most lawsuits around dangerous drugs are the result of the drug leading to severe physical damage. However, the Abilify lawsuit is from more intangible damages. Those who developed compulsive gambling habits and lost over $75,000 or those who developed compulsive sexual habits should contact an Abilify Lawsuit Attorney right away.
An Abilify Lawsuit Attorney can help you right the wrongs of this dangerous drug.
What Kind of Compensation Can I receive in an Abilify Lawsuit?
You may be eligible for compensation through a lawsuit if you’ve experienced an Abilify compulsive behavior. If this behavior resulted in financial, mental and physical damages, you might able to seek compensation. If you have experienced gambling losses in the tens of thousands of dollars, you might be able to pursue the following damages:
- Past and future medical expenses to treat your addiction
- Past and future mental pain and suffering caused by your addiction (such as loss of family, friends, employment and finances)
- Wage loss
- Gambling losses
- Other economic losses you sustained because of your Abilify compulsive behavior
- Punitive damages, if appropriate
More than 1,600 lawsuits have been filed in federal court against Abilify manufacturers. These cases are by individuals who have compulsive behaviors as a result of the drug. Contact an Abilify Lawsuit Attorney from The Carlson Law Firm to discuss your Abilify Lawsuit.
The Carlson Difference
The Carlson Law Firm is representing clients who suffered serious financial loss as a result of an Abilify compulsive behavior. Otsuka Pharmaceutical Company and Bristol-Myers Squibb had an obligation to inform customers of the link between Abilify and impulsive behaviors. If you or a loved one suffered serious economic damages from Abilify compulsive behavior contact The Carlson Law Firm.
The makers of Abilify knew of the kind of damages the drug caused before adding the dangers to the label. If your incurred thousands of dollars in gambling debt or experienced compulsive sexual habits after taking Abilify, contact us today. An Abilify Lawsuit Attorney from The Carlson Law Firm can help you get the compensation you need to rebuild your life.
The Carlson Law Firm has more than 40 years of experience helping victims of dangerous drugs. Additionally, we are dedicated to protecting your rights and ensuring that your recover a just and fair compensation for your injuries. The Abilify Lawsuit Attorneys at The Carlson Law Firm is ready to evaluate your case.